Science topic
Endothelial Function - Science topic
Explore the latest questions and answers in Endothelial Function, and find Endothelial Function experts.
Questions related to Endothelial Function
I'm planning to assess endothelial function in animal model of hyperglycemia .
I detect the protein expression of enos(nos3) in huvec and cannot get results with enos.The expression of other proteins are strong enough to detect .The only one cannot be detect is enos .
I extracted the total protein of HUVEC. Also, the final concentration of total protein is about 5mg/ml.
So ,I need anyone who detected enos in huvec by western blot to help me .
Thank you for your attention .
I am interested in studying all the physiological, neural, endocrine mechanisms associated with different breathing exercises suggested by traditional pranayama - such as ujjayi, bhramari, nadi suddhi, kapala bhaati, breath holding - and also other newer techniques. As part of this, I want to study how the endothelial functions change due to some of these practices. Hence, the question. I did not formally study biology or human physiology at any time. So, I have a lot of gaps in my knowledge w.r.t. human anatomy and physiology. I shall be grateful, if anyone can point me to good sources of information about the above, and also distinguished researchers who have contributed original knowledge in this field.
Several standard buffer recipes have 11 mM glucose, and also sucrose. I realise buffers need osmolarity, but why such high sugar concentrations?
I used to use Holmans in myograph experiments, and at one point investigated the effects of high glucose on endothelial function. Couldn't help thinking my control preparations were already "hyperglycaemic".
Never had a satisfactory answer to this question.
I am in the process of writing my systematic review in which I asses the longitudinal association between baseline endothelial function and diabetes type II at follow up in healthy participants. we selected only cohort studies. most of the studies didn't report the analysis between these two measures so we had to ask the authors for multivariate regression and they reported beta, standard error and significance. the analysis they did for endothelial function measure (FMD or RHI) and diabetes status measure (fasting plasma glucose or HbA1c) reported by 3 studies is insignificant as p value was insignificant. only one study reported baseline endothelial function and incidence of diabetes at follow up with significant relative ratio. and it matches with our hypothesis. now I have to conclude and discuss this two different outcome and build my case around it.
i want to ask that what things and factors I should consider in building my discussion. Any help in any direction would be very helpful. I feel like having two different outcomes is the key here but what could I use to differentiate between the two outcomes?
Thank you
I have longitudinal data with 2 follow ups at year 1 and 3. At baseline we have measure of endothelial function and we want to calculate the relation ship between endothelial function and diabetes type II. at follow up, the incidence of diabetes is recorded with self reported diagnosis or use of medication as the follow up was only done through interviews and questionnaire. we dont have the exact date of incidence of diabetes. which analysis method will be best to use for this type of data. survival analysis or mixed model? I understand for survival analysis I would need exact date of diagnosis of diabetes. but is there other assumptions that can make it possible to use it?
I'm trying to get flow mediated dilation data to assess endothelial function using Reactive Hyperemia ( Occlusion).
What would be the best option to
a) get the data from one arm , take baseline measurement then occlude and get data during post reactive hyperemia.
b) consider one arm baseline measurement and use other arm for occlusion and get post reactive hyperemia data.
It has been well documented that the TNF-alpha treatment of endothelial cells will significantly increase the expression levels of adhensive proteins, i.e. ICAM-1 and VCAM-1. Recently, I tried to used the TNF-alpha (Invitrogen) with different concentration (10, 100, 500 ng/mL) to treat the HUVECs for 48h. Then I did the immunostaining of ICAM-1 and VCAM-1, but I cannot see the expression differnece between treated HUVECs and untreated cells. I tried a couple of times and it did not work. Can anyone give some advice on this ? Thanks so much!
The view that shear is constant across the circulation appears to be dwindling, but is the view that shear increases in small arteries/microcirculation still controversial, or is there now a consensus?
Studies of NO-independent, hyperpolarization-mediated relaxation using myography often use the selective BKCa blocker iberiotoxin to delineate the role of transferable EDHFs, such as EETs or H2O2. More thorough studies demonstrate transferability through cascade or serial perfusion bioassays, but the majority of studies simply use iberiotoxin sensitive relaxation to "demonstrate" EDHF-type activity. The reality is that BKCa channels are activated prior to stimulation due to their intrinsic sensitivity to increased voltage, occurring following the induction of smooth muscle tone, thereby limiting the development of tone. Therefore, is it not just as likely that iberiotoxin sensitive relaxation is simply a reflection of BKCa no longer being able to limit tone?
As I say, there ways to further substantiate the significance of an EDHF, but are those using just simple myography to arrive at that conclusion making an over-assumption?
This may be an amateurish question, but it is a minor point outside my expertise that I want clarification. As an example, cytochrome P450 epoxygenases are often found in microsomes of vascular endothelial cells. Does this mean they are present in the ER of the intact endothelial cell?
As I understand it, normal endothelial cells grow in-vivo on a basal lamina which notably includes collagen IV.
I recently read a paper which attempted to test JNK activation and atherosclerotic lesion formation in response to various basal laminae, including collagen and fibronectin. BAECs were used and were subjected to shear stress in a parallel-plate flow chamber.
However, what caught my eye was that they used collagen I instead of collagen IV in the course of their experiment. Hence, is there any reason in general for using collagen I instead of collagen IV in the course of the experiment?
Thanks for the answers. Of course I'm not expecting anyone to read the paper, but I'd just like to know if there was any reason that is not specific to this paper alone.
Particularly interested in published data demonstrating this, if anyone knows of any.
hi anyone
I want to do cell culture in the inner surface of a tubular scaffold for vascular tissue engineering with the aim of regenerate a small diameter artery. but there is two limit case. first the time is short to cell death and second the adhesion of cell must be so strong for standing under shear stress.
now what is your suggest for me? with method is the best?
What is the problem of the internal thoracic artery that feeds the mammary, when precontracted with NE and ANG II that leads to wobbling of the curve as you see in the attachment images.
Can anyone tell me what the problem is?
Cytokines involved in endothelial dysfunctions.
During organ bath, I am using aorta as a model, how I know that the function of endothelium detoriated beside using acetylcholine?
All methods to remove aortic endothelial cell and which one are the best?
Diabetes has many complications, one of which is on reproduction (infertility). How can I mimic diabetes condition in a testes cell line? I have seen papers in which a pancreas (beta cell line) has been grown in high and low glucose to mimic diabetic conditions.
Our favourite kit is no longer available. We need advice about other kits and how they are working out for you, to find a new favourite.
I have been infusing rats with angiotensin II, which causes severe vasoconstriction and probably should induce systemic hypoxia. How could I prove my hypothesis? I’m looking for a molecule or something that I could determine by ELISA. Does someone have experience with systemic hypoxia and HIF expression in the body?
I have assessed endothelial function after acute exercise by peripheral arterial tonometry (endoPAT). The results for RHI declined after exercise, although the flow-mediated dilation assessed by ultrasonography increased.